Systemic Immune Activation Profiles of HIV-1 Subtype C-Infected Children and Their Mothers

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Makhubele, Tinyiko G ^a   Steel, Helen C ^a   Anderson, Ronald ^a   Van Dyk, Gisela ^a   Theron, Annette J ^a,b   Rossouw, Theresa M ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CD14 ANTIGEN; COTRIMOXAZOLE; CXCL9 CHEMOKINE; EFAVIRENZ; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RITONAVIR; TRANSFORMING GROWTH FACTOR BETA1; ZIDOVUDINE; BIOLOGICAL MARKER; CXCL10 PROTEIN, HUMAN; CXCL9 PROTEIN, HUMAN;

ADULT; ARTICLE; CHILDHOOD DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE C; IMMUNONEPHELOMETRY; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; MATERNAL SMOKING; MOTHER CHILD RELATION; NEPHELOMETRY; PRIORITY JOURNAL; BLOOD; CHILD; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METABOLISM; MOTHER; PRESCHOOL CHILD; YOUNG ADULT;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOMARKERS; C-REACTIVE PROTEIN; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; MOTHERS; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84960984207     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/9026573     Document Type: Article

References (36)

1. M. Paiardini and M. Müller-Trutwin, "HIV-associated chronic immune activation, " Immunological Reviews, vol. 254, no. 1, pp. 78-101, 2013.
2. V. Appay and D. Sauce, "Immune activation and inflammation in HIV-1 infection: causes and consequences, " The Journal of Pathology, vol. 214, no. 2, pp. 231-241, 2008.
3. G. d'Ettorre, M. Paiardini, G. Ceccarelli, G. Silvestri, and V. Vullo, "HIV-associated immune activation: from bench to bedside, " AIDS Research and Human Retroviruses, vol. 27, no. 4, pp. 355-364, 2011.
4. A. Kamat, V. Misra, E. Cassol et al., "A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy, " PLoS ONE, vol. 7, no. 2, Article ID e30881, 2012.
5. G. Malherbe, H. C. Steel, S. Cassol et al., "Circulating biomarkers of immune activation distinguish viral suppression from nonsuppression in HAART-treated patients with advanced HIV-1 subtype C infection, " Mediators of Inflammation, vol. 2014, Article ID 198413, 7 pages, 2014.
6. T. L. Miller, W. Borkowsky, L. A. Dimeglio et al., "Metabolic abnormalities and viral replication are associatedwith biomarkers of vascular dysfunction in HIV-infected children, " HIV Medicine, vol. 13, no. 5, pp. 264-275, 2012.
7. T. Sainz, M. Álvarez-Fuente, and M. L. Navarro, "Structural changes of the arterial wall appear in first decades of life during HIV-infection, " Journal of Acquired Immune Deficiency Syndromes, vol. 65, no. 1, pp. 42-49, 2014.
8. A. M. Sánchez Torres, R. MunozMuniz, R. Madero, C. Borque, M. J. Garca-Miguel, andM. I. De JoséGómez, "Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children, " European Journal of Pediatrics, vol. 164, no. 5, pp. 271-276, 2005.
9. T. L. Miller, E. J. Orav, S. E. Lipshultz et al., "Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1, "The Journal of Pediatrics, vol. 153, no. 4, pp. 491-497, 2008.
10. T. L. Miller, Y. T. Grant, D. N. Almeida, T. Sharma, and S. E. Lipshultz, "Cardiometabolic disease in human immunodeficiency virus-infected children, " Journal of the Cardiometabolic Syndrome, vol. 3, no. 2, pp. 98-105, 2008.
11. M. Yoshioka, W. G. Bradley, P. Shapshak et al., "Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases, " Advances in Neuroimmunology, vol. 5, no. 3, pp. 335-358, 1995.
12. E. Chiappini, E. Berti, K. Gianesin et al., "Pediatric human immunodeficiency virus infection and cancer in the highly active antiretroviral treatment (HAART) era, " Cancer Letters, vol. 347, no. 1, pp. 38-45, 2014.
13. S. F. van Eeden and J. C. Hogg, "The response of human bone marrow to chronic cigarette smoking, " The European Respiratory Journal, vol. 15, no. 5, pp. 915-921, 2000.
14. N. R. Reynolds, "Cigarette smoking andHIV:more evidence for action, " AIDS Education and Prevention, vol. 21, supplement 3, pp. 106-121, 2009.
15. L. R. Pacek and R. M. Crum, "A review of the literature concerning HIV and cigarette smoking: morbidity and mortality, associations with individual-and social-level characteristics, and smoking cessation efforts, " Addiction Research & Theory, vol. 23, no. 1, pp. 10-23, 2015.
16. D. P. Strachan and D. G. Cook, "Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood, " Thorax, vol. 52, no. 10, pp. 905-914, 1997.
17. L. L. Jones, A. Hashim, T. McKeever, D. G. Cook, J. Britton, and J. Leonardi-Bee, "Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and metaanalysis, " Respiratory Research, vol. 12, article 5, 2011.
18. N. L. Benowitz, K. E. Schultz, C. A. Haller, A. H. Wu, K. M. Dains, and P. Jacob III, "Biochemical verification of tobacco use and cessation, " Nicotine & Tobacco Research, vol. 4, no. 2, pp. 149-159, 2002.
19. E. J. Abrams, J. Weedon, R. W. Steketee et al., "Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants, " The Journal of Infectious Diseases, vol. 178, no. 1, pp. 101-108, 1998.
20. M. Muechhoff, A. J. Prendergast, and P. J. Goulder, "Immunity to HIV in early life, " Frontiers in Immunology, vol. 5, no. 391, 2014.
21. N. R. Klatt, N. T. Funderburg, and J. M. Brenchley, "Microbial translocation, immune activation, and HIV disease, " Trends in Microbiology, vol. 21, no. 1, pp. 6-13, 2013.
22. N. Liappis, "Reference values of 2 microglobulin concentrations in the serumof children, " Klinische Pädiatrie, vol. 200, no. 1, pp. 67-69, 1988 (German).
23. E. Papasavvas, L. Azzoni, A. Foulkes et al., "Increased microbial translocation in ?180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age, " The Pediatric Infectious Disease Journal, vol. 30, no. 10, pp. 877-882, 2011.
24. K. Crothers, T. A. Griffith, K. A. McGinnis et al., "The impact of cigarette smoking onmortality, quality of life, and comorbid illness among HIV-positive veterans, " Journal of General Internal Medicine, vol. 20, no. 12, pp. 1142-1145, 2005.
25. J. G. Feldman, H. Minkoff, M. F. Schneider et al., "Association of cigarette smoking with HIV prognosis among women in the HAART era: a report fromthe women's interagencyHIV study, " American Journal of Public Health, vol. 96, no. 6, pp. 1060-1065, 2006.
26. S. Nahvi and N. A. Cooperman, "Review: the need for smoking cessation among HIV-positive smokers, " AIDS Education and Prevention, vol. 21, supplement 3, pp. 14-27, 2009.
27. M. Helleberg, S. Afzal, G. Kronborg et al., "Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study, " Clinical Infectious Diseases, vol. 56, no. 5, pp. 727-734, 2013.
28. M. J. Miguez-Burbano, D. Ashkin, A. Rodriguez et al., "Increased risk of Pneumocystis carinii and communityacquired pneumonia with tobacco use in HIV disease, " International Journal of Infectious Diseases, vol. 9, no. 4, pp. 208-217, 2005.
29. T. M. Rossouw, R. Anderson, and C. Feldman, "Impact of HIV infection and smoking on lungimmunity and related disorders, " The European Respiratory Journal, vol. 46, no. 6, pp. 1781-1795, 2015.
30. P. Waweru, R. Anderson, H. Steel, W. D. F. Venter, D. Murdoch, and C. Feldman, "The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV-positive patients in Johannesburg, South Africa, " SouthAfricanMedical Journal, vol. 103, no. 11, pp. 858-860, 2013.
31. G. M. Louwagie and O. A. Ayo-Yusuf, "Tobacco use patterns in tuberculosis patients with high rates of human immunodeficiency virus co-infection in South Africa, " BMC Public Health, vol. 13, article 1031, 2013.
32. B. R. Lane, S. R. King, P. J. Bock, R. M. Strieter, M. J. Coffey, and D. M. Markovitz, "The C-X-C chemokine IP-10 stimulates HIV-1 replication, " Virology, vol. 307, no. 1, pp. 122-134, 2003.
33. A. A. Farhang and F. A. Qadir, "Effects of cigarette smoking on some immunological and hematological parameters in male smokers in Erbil city, " Jordan Journal of Biological Sciences, vol. 6, no. 2, pp. 159-166, 2013.
34. C. Costa, R. Rufino, S. L. Traves, J. R. Lapa E Silva, P. J. Barnes, and L. E. Donnelly, "CXCR3 and CCR5 chemokines in induced sputumfrom patients with COPD, " Chest, vol. 133, no. 1, pp. 26-33, 2008.
35. A. J. Montpetit, Modulation of monocyte-derived dendritic cell maturation and function by cigarette smoke condensate in a bronchial epithelial cell co-culture model [Ph. D. thesis], Graduate Theses and Dissertations, 2008, http://scholarcommons. usf. edu/etd/413.
36. E. Stylianou, P. Aukrust, K. Bendtzen, F. Müller, and S. S. Frøland, "Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN- in HIV infection, " Clinical and Experimental Immunology, vol. 119, no. 3, pp. 479-485, 2000.